Back
Zevra Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55
ZVRA
Zevra Therapeutics
Last Price:
$12.66
Seasonality Move:
11.56%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVRA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Zevra Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.28 | Buy |
20-day SMA: | 10.51 | Buy |
50-day SMA: | 9.36 | Buy |
200-day SMA: | 8.39 | Buy |
8-day EMA: | 10.79 | Buy |
20-day EMA: | 6.81 | Buy |
50-day EMA: | 3.37 | Buy |
200-day EMA: | 0.94 | Buy |
Zevra Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.47 | Buy |
Relative Strength Index (14 RSI): | 77.8 | Buy |
Chaikin Money Flow: | 1000605 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.75 - 11.73) | Buy |
Bollinger Bands (100): | (7.06 - 9.84) | Buy |
Zevra Therapeutics Technical Analysis
Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Zevra Therapeutics Stock
Is Zevra Therapeutics Stock a Buy?
-
Zevra Therapeutics share price is 12.66 while ZVRA 8-day simple moving average is 12.28, which is a Buy signal.
-
The stock price of ZVRA is 12.66 while Zevra Therapeutics 20-day SMA is 10.51, which makes it a Buy.
-
Zevra Therapeutics 50-day simple moving average is 9.36 while ZVRA share price is 12.66, making it a Buy technically.
-
ZVRA stock price is 12.66 and Zevra Therapeutics 200-day simple moving average is 8.39, creating a Buy signal.
ZVRA Technical Analysis vs Fundamental Analysis
Buy
55
Zevra Therapeutics (ZVRA)
is a Buy
Is Zevra Therapeutics a Buy or a Sell?
-
Zevra Therapeutics stock is rated a BuyThe current Zevra Therapeutics [ZVRA] share price is $12.66. The Score for ZVRA is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Zevra Therapeutics Stock Info
Market Cap:
692.2M
Price in USD:
12.66
Share Volume:
1.5M
Zevra Therapeutics 52-Week Range
52-Week High:
13.16
52-Week Low:
5.45
Buy
55
Zevra Therapeutics (ZVRA)
is a Buy
Zevra Therapeutics Share Price Forecast
-
What is the Zevra Therapeutics stock price today?The Zevra Therapeutics stock price is 12.66 USD today.
-
Will ZVRA stock go up or go down?Zevra Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Zevra Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Zevra Therapeutics is not overvalued.
Is Zevra Therapeutics Stock a Buy?
-
Zevra Therapeutics share price is 12.66 while ZVRA 8-day exponential moving average is 10.79, which is a Buy signal.
-
The stock price of ZVRA is 12.66 while Zevra Therapeutics 20-day EMA is 6.81, which makes it a Buy.
-
Zevra Therapeutics 50-day exponential moving average is 3.37 while ZVRA share price is 12.66, making it a Buy technically.
-
ZVRA stock price is 12.66 and Zevra Therapeutics 200-day simple moving average is 0.94, creating a Buy signal.
Fundamental Analysis of Zevra Therapeutics
Is Zevra Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.37 per share, an increase next quarter of $0.23 per share, an increase this year of $3.37 per share, and a decrease next year of $0.81 per share.
Technical Analysis of Zevra Therapeutics
Should I short Zevra Therapeutics stock?
-
ZVRA Moving Average Covergence Divergence (MACD) indicator is 3.47, suggesting Zevra Therapeutics is a Buy
-
Zevra Therapeutics Relative Strength Index (RSI) is 77.8, which suggest Zevra Therapeutics is overbought
-
The Bollinger Bands (25) for Zevra Therapeutics is (8.75 - 11.73), which suggest Zevra Therapeutics is a Buy
-
The Bollinger Bands (100) for Zevra Therapeutics is (7.06 - 9.84), which suggest Zevra Therapeutics is a Buy
* Zevra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.